Who Can Inject Botox in the United States? By Role and By State (2026)

Few questions matter more to a med spa operator than who, exactly, is allowed to push the plunger on a Botox syringe. The answer feels like it should be simple — a national drug, an FDA label, a treatment millions of patients receive every year — and yet there is no single national rule. The federal government approves Botox as a prescription drug. The states decide who can prescribe it, who can administer it, what supervision looks like, and what counts as a legitimate provider-patient relationship in the first place.

This guide is organised the way the question is actually asked: role first, state second. Each licence type gets its own section and a direct verdict sentence at the top, so you can find your answer without reading the whole page. The licensed practical nurse section is the longest, because it is where the rules are least uniform, most misunderstood, and most likely to be misstated by training companies selling certification courses.

Important: Scope of practice changes more often than most operators realise, and several of the sources that circulate online are simply wrong. Verify current rules with your state's medical board, board of nursing, and board of pharmacy or dentistry before making compliance decisions. This reference reflects rules as of August 2026. Where a state has genuinely not spoken, this guide says so rather than guessing.

The national picture: why this is decided state by state

The Food and Drug Administration approved onabotulinumtoxinA (Botox) in 1989 for medical indications and in 2002 for cosmetic glabellar lines, with subsequent expansions for crow's feet, forehead lines, and other cosmetic and therapeutic uses. Botox is a federal legend (prescription-only) drug — it cannot be sold or administered without a prescription from a licensed prescriber. That federal floor is set out in the FDA-approved Botox label and is identical in every state.

What the federal government does not do is define who counts as a prescriber, who counts as an authorised administrator, or what supervision arrangement is legally sufficient. Those questions live inside each state's Medical Practice Act, Nurse Practice Act, Dental Practice Act, and Pharmacy Practice Act. The phrase "the practice of medicine" is defined by state statute, and so is the corresponding nursing scope. A nurse practitioner who can independently prescribe and inject Botox in Arizona may legally need a written collaborative agreement to do exactly the same thing in Florida.

Three questions every state answers separately

Any scope analysis resolves into three distinct questions, and states answer them independently of one another. Operators get into trouble by assuming that a yes to one implies a yes to the others.

Who may prescribe? This is the authority to evaluate the patient, decide that Botox is indicated, and issue the order. Physicians hold it everywhere. NPs and PAs hold it subject to state conditions. Registered nurses never hold it. Who may administer? This is the authority to physically perform the injection under someone else's order. It reaches further down the licence ladder than prescribing authority does — most obviously to RNs, and in a small number of states to LPNs. Who may own the entity? This is corporate practice of medicine, an entirely separate doctrine, and a licence that permits injection does not imply a licence to own the practice that offers it.

Why "certification" is not scope

The most expensive misconception in this industry is that a training certificate creates legal authority. It does not, anywhere, for anyone. Private Botox certification courses are education, not licensure. A weekend course does not enlarge a medical assistant's scope, does not convert an esthetician into an injector, and does not override a nurse practice act. When a state board evaluates whether an injection was lawful, it looks at the licence held and the delegation on file — the certificate is at most evidence of competency, and competency only matters once the act is already within scope.

The three regulatory models

Strip away the state-by-state detail and the country sorts into three models for authorising cosmetic injection. Knowing which model your state uses tells you what kind of document you need before anyone injects.

Model one: express board guidance. The state board of nursing (or medicine) has published a position statement, advisory opinion, or declaratory statement that names cosmetic injectables directly and says which licence levels may perform them. North Carolina, Kentucky, Washington, Nevada, Georgia, and Florida sit here. This is the most useful model for operators because the answer is written down and citable.

Model two: general delegation statute with no cosmetic-specific guidance. The state has a physician delegation rule and a nurse practice act, but has never addressed neuromodulators specifically. Most states sit here. The analysis is a reasoning exercise: does this act require independent nursing assessment beyond the licence level in question? For LPNs, the usual answer is yes, which is why the conservative reading is no.

Model three: prescriptive statutory schemes. A handful of states impose facility-level or procedure-level requirements on top of the licence question — Texas physician delegation orders, Florida office surgery rules, New York's Education Law §6521 and Public Health Law §238-a. Here, satisfying the licence question is necessary but not sufficient; the entity structure must also comply.

Physicians (MD/DO): the baseline verdict

Verdict: yes, in every state, with no supervision requirement. A licensed physician holding an active licence in the state where the patient is physically located may evaluate, prescribe, and inject Botox and dermal fillers without any additional authorisation.

The only meaningful constraint on a physician is licensure geography. A California-licensed physician cannot lawfully prescribe to a patient sitting in Florida unless that physician also holds a Florida licence or fits a narrow telehealth exception. The Interstate Medical Licensure Compact, now covering 40+ states, accelerates obtaining additional state licences but does not eliminate the per-state requirement. This trips up telehealth-mediated med spa chains constantly, and it is one of the most reliably prosecuted violations in the sector.

Board certification is not a scope question

No state restricts cosmetic injection to dermatologists or plastic surgeons. A family medicine physician, an emergency physician, and a board-certified plastic surgeon have identical legal authority to inject Botox. Specialty training affects the standard of care in a malpractice action — it does not affect scope of practice. Practices that advertise "board-certified injector" should be careful: unless the certifying body is an ABMS or AOA member board, the phrase can itself trigger a deceptive-advertising complaint in several states.

The medical director layer

A physician serving as a med spa's medical director takes on obligations beyond their own injection authority — establishing standing orders, signing SOPs, supervising delegated staff, and remaining genuinely accountable for clinical operations. Several states have moved against arrangements where the medical director's involvement is nominal. For the director-specific rules, see our medical director requirements guide.

Physician assistants: authorised everywhere, always through delegation

Verdict: yes, in every state, under a supervising physician's written delegation or practice agreement. PAs may perform the good-faith examination, prescribe, and inject, and in most states they may also authorise a registered nurse to administer under their order.

PA scope is markedly more uniform than NP scope. In every U.S. state a PA practises under physician supervision and may prescribe and inject Botox and fillers under a written delegation order or supervisory agreement. The American Academy of Physician Associates maintains current state practice information at aapa.org.

What varies for PAs between states

Three variables move state to state. First, the documentation expected — Texas requires an explicit written delegation instrument that the Texas Medical Board enforces, while New York requires written practice agreements detailing the scope of delegated services. Second, the supervising physician's required availability, which ranges from physical presence for certain acts to telephonic reachability. Third, the ratio of PAs a single physician may supervise, which is capped in some states and uncapped in others. None of these change the core answer: a PA can inject.

Can a PA be the med spa's prescribing authority?

Generally yes for clinical purposes — a PA can perform the good-faith exam and write the standing order that an RN administers under. What a PA usually cannot do is serve as the legal medical director of the entity or satisfy a state's physician-ownership requirement. Those are corporate-structure questions, not scope questions, and they are answered by the CPOM doctrine rather than the PA practice act.

Nurse practitioners and APRNs: the biggest state-to-state variable

Verdict: yes in every state, but whether a physician must be involved depends entirely on your state's practice-authority tier. In full practice authority states an NP may evaluate, prescribe, inject, and own the practice. In restricted states, injection without a current written collaborative or protocol agreement is unauthorised — even though the NP is fully licensed.

The American Association of Nurse Practitioners maintains the canonical map at the AANP State Practice Environment page. As of AANP's May 2026 update, 27 states plus Washington, D.C. grant full practice authority: Alaska, Arizona, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Kansas, Maine, Maryland, Massachusetts, Minnesota, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Dakota, Oregon, Rhode Island, South Dakota, Utah, Vermont, Washington, and Wyoming. Counts of 28 to 30 circulate because some sources include states whose recent legislation AANP has not yet reflected.

Full practice authority states

In these states an NP can own a med spa outright, perform the good-faith examination, write the standing order, and inject — with no physician anywhere in the chain. Arizona is the cleanest exemplar; see our Arizona NP full practice authority guide. One caution: full practice authority is a nursing-board concept and does not automatically resolve the state's corporate practice or facility-licensing rules.

Transitional and conditional states

Several states grant independence only after a threshold is met. New York's 3,600-hour rule is the best known — an NP who completes 3,600 hours of qualifying practice may drop the collaborative agreement, which is why AANP counts New York as full practice, but a New York NP still cannot serve as the legal medical director of a med spa entity (see our New York 3,600-hour NP rule guide). California's AB-890 created the "104 NP" category permitting independent practice in designated settings after transition-to-practice requirements are met (see our California AB-890 NP guide). In both states the entity-level medical director role still requires a physician.

Restricted and reduced states

Florida (where NPs are ARNPs), Texas, Georgia, Ohio, North Carolina, and others require a written collaborating, supervising, or protocol agreement covering prescribing and delegated services. Georgia is the clearest example: a written APRN protocol agreement signed by both the NP and the supervising physician, defining prescriptive authority and delegated scope. See our Georgia NP protocol agreement guide. The operational point is unforgiving: in these states, a lapsed or unsigned agreement makes every injection the NP performs technically unauthorised, regardless of skill or years of experience.

Registered nurses: the workhorse role, with one hard limit

Verdict: yes in effectively every state, under a prescriber's good-faith examination and order — but an RN may never perform the good-faith examination or prescribe.

Registered nurses are the largest group of aesthetic injectors in the country. The RN's role is administrative within a clinical chain the prescriber owns: the prescriber (MD, DO, NP, or PA depending on state) evaluates the patient, performs the good-faith exam, writes the treatment plan, and authorises the RN by standing order or specific written order. The RN then injects, documents, and escalates adverse events. That division of labour is consistent across all fifty states.

What changes between states for RNs

Three things vary. How immediately reachable the prescriber must be — some states require on-site presence for the first treatment, most require only reachability for follow-ups. Whether telehealth good-faith exams are accepted, and under what documentation standard. And how prescriptive the standing-order paperwork must be, which ranges from a signed protocol to a patient-specific written order. Florida is illustrative of how unsettled even a well-covered state can be: the Florida Board of Nursing has issued more than one declaratory statement on RN injection, and practitioners there routinely describe the resulting position as conditional rather than a blanket yes.

What an RN can never do, in any state

An RN cannot perform the initial good-faith exam, write a prescription, treat a new patient the prescriber has not evaluated, or authorise a standing order on their own signature. RNs also cannot supervise other RNs for cosmetic injection purposes — that supervision must come from a prescriber. The Nurse Licensure Compact, maintained by NCSBN, lets RNs practise across compact states on one multistate licence but changes no underlying scope rule.

Licensed practical nurses and LVNs: the most misunderstood licence

Verdict: in most states, no — but this is the one role where the blanket "never, anywhere" answer you will read elsewhere is genuinely wrong. A small number of state boards have expressly brought neuromodulator administration within LPN scope under conditions. Most states have never addressed it, and in those states the conservative and defensible reading is that it falls outside LPN scope.

Licensed Practical Nurses — called Licensed Vocational Nurses in California and Texas — hold a licence defined by each state's Nurse Practice Act, and that scope is uniformly narrower than RN scope. The recurring theme in board reasoning is independent assessment. Cosmetic injection requires evaluating facial anatomy, selecting injection points, judging dose against a dynamic clinical picture, and recognising a vascular event in real time. Boards that exclude LPNs do so because that judgment exceeds the LPN's licensed decision-making authority — not because the physical act of injecting is beyond them.

Why the usual sources get this wrong

Two errors dominate. The first is over-generalisation: many guides assert LPNs cannot inject in any state, which is contradicted by North Carolina's own published position statement. The second is over-claiming, usually by training vendors: sites that list Texas as an LPN-friendly state because "LVNs can inject under physician delegation." That is incorrect. The Texas Board of Nursing treats cosmetic injectables as requiring independent clinical judgment outside LVN scope, and no written protocol or physician presence cures it. We found both errors repeatedly while researching this page, occasionally in the same article.

The three states that have expressly permitted it

North Carolina is the clearest yes in the country. The North Carolina Board of Nursing's position statement on cosmetic and aesthetic dermatological procedures places Botox and dermal filler injection within the scope of both RNs and LPNs, provided the procedure is ordered by a licensed provider with prescriptive authority acting within their own scope, and the nurse holds documented training and demonstrated competency. The board draws an explicit line between the two licences: an RN does not require the prescribing provider on site, while an LPN must have direct, on-site supervision from an RN, physician, NP, or other qualifying provider. Separately, LPNs cannot own or co-own a professional nursing entity in North Carolina, so an LPN cannot build a solo practice on this authority.

Kentucky permits a competent and appropriately trained LPN to administer neuromodulators such as Botox, Dysport, or Xeomin under the direction of a qualified healthcare provider, or under the direction and supervision of a registered nurse, with a prescription from a qualified provider. The Kentucky Board of Nursing routes practitioners to its advisory opinion statements — AOS #35 on the role of nurses in cosmetic and dermatological procedures, and AOS #41 on RN/LPN/APRN scope — to confirm the act sits within both the legal scope of the licence and the individual nurse's demonstrated competency.

Washington permits appropriately trained LPNs to administer neuromodulators under the required direction and prescription rules. The Washington nursing commission's advisory opinion on cosmetic, aesthetic, and dermatologic procedures addresses LPN performance of these procedures within the legal parameters, competencies, and practice standards of the licence, carried out under the direction of an authorised health care practitioner. As in Kentucky, the authority is conditional on documented competency, not automatic with the licence.

The states that have expressly said no

Texas is unambiguous: the Board of Nursing's scope for LVNs does not include procedures demanding the independent clinical judgment cosmetic injectables require. A physician in the building, a written protocol, and a private certification course do not change the answer. Nevada's State Board of Nursing aesthetic practice decision, approved 17 January 2025, lists neuromodulators as outside LPN scope. Georgia's Board of Nursing position statement places cosmetic neuromodulator injection within RN scope and not LPN scope. Florida limits LPN practice such that cosmetic injectables fall outside it — the Florida board's declaratory statements on Botox address RNs, not LPNs. New York does not authorise LPNs to perform cosmetic injectable procedures. California's framework names physicians, RNs, PAs, and NPs as authorised injectors; LVNs are not among them.

The states that have not spoken

This is the largest group, and honesty matters more here than completeness. In most states the board of nursing has issued no position statement, advisory opinion, or declaratory ruling that names cosmetic neuromodulators and LPN scope in the same document. Silence is not permission. When a board later evaluates a complaint in a silent state, it applies the general scope analysis — and that analysis has produced a no in every state that has run it publicly except the three above. Treat silence as a no, and if you need a different answer, request a formal scope determination from your board in writing rather than relying on a vendor's chart.

What States Can an LPN Inject Botox? A State-by-State Table

The table below gives every U.S. state and the District of Columbia. Three verdicts are used. Yes — with conditions means the board has published guidance expressly bringing neuromodulator administration within LPN scope subject to supervision and competency requirements. No — board has addressed it means a board statement, practice decision, or established framework expressly excludes LPNs. Not squarely addressed means we could not locate a board document naming cosmetic neuromodulators and LPN scope together; the conservative reading is no, and you should confirm in writing with your board before relying on anything else.

A note on New Jersey

"Can an LPN inject Botox in NJ" is one of the most common versions of this question, and it deserves a straight answer: we could not locate a New Jersey Board of Nursing document that addresses LPN scope and cosmetic neuromodulators together. New Jersey RNs may administer aesthetic injectables under a physician's delegation and established protocols. We specifically checked a claim circulating online that N.J.A.C. 13:35-4A.12(d) makes Botox a non-delegable, physician-only procedure — that citation does not support the claim, because that section concerns an alternative privileging procedure for office-based surgery, not injectable delegation. Do not rely on it in either direction. Until the board says otherwise, an LPN injecting in New Jersey is taking an unquantified risk, and the right move is a written scope determination request to the board.

How to get a real answer for your state

If your state is in the "not squarely addressed" column and the answer matters commercially, do not settle for a chart. Search your board's site for "position statement," "advisory opinion," and "declaratory statement" alongside "cosmetic," "aesthetic," and "dermatologic" — the cosmetic guidance is almost never in the practice act itself. Then submit a written scope-of-practice inquiry. Most boards answer in writing within a few weeks, and that letter is the document that protects you in an investigation. A vendor's state chart is not.

Pharmacists: can a pharmacist inject Botox?

Verdict: no state authorises a pharmacist to inject Botox for cosmetic purposes in their capacity as a pharmacist. Pharmacist injection authority in the United States is built around immunisations and a defined set of therapeutic medications under protocol or collaborative practice agreement — not cosmetic neuromodulators.

The query "what states can pharmacists inject botox" gets asked frequently, and the honest answer disappoints. Every state now permits pharmacists to administer vaccines, and a growing number allow long-acting injectables such as antipsychotics or contraceptives under a collaborative practice agreement or statewide protocol. That expansion is real, but it is drug-class specific. It authorises the pharmacist to administer the medications named in the protocol. No state pharmacy practice act or board protocol we could identify names botulinum toxin for cosmetic indications.

Why vaccine authority does not extend to neuromodulators

Three differences drive the outcome. Vaccine administration is intramuscular or subcutaneous into a standardised site with a fixed dose — cosmetic neuromodulator injection requires facial anatomical assessment and individualised dosing across multiple muscle groups. Vaccine protocols exist because there is a public-health rationale and a statewide standing order; cosmetic treatment has neither. And the adverse-event profile differs: ptosis, diffusion into adjacent muscles, and vascular events with fillers require the practitioner to hold the assessment scope to recognise and manage them.

The one path that does work

A pharmacist who also holds a separate clinical licence — RN, NP, PA, or physician — may inject under that other licence, subject to that licence's rules. This is not a pharmacist exception; it is simply a person with two credentials acting under the one that authorises the act. Dual-credentialed pharmacist-NPs are the most common version. If you are a PharmD considering aesthetics and do not hold a second clinical licence, the realistic route is obtaining one, not finding a permissive state.

What about older claims that Virginia or South Carolina allow it?

Forum posts from the mid-2010s occasionally claim pharmacists could administer Botox and dermal fillers in Virginia and South Carolina. We could not verify either claim against current board sources, and we would not act on a decade-old forum post regardless. If you believe your state authorises it, get the citation from the board of pharmacy in writing before injecting.

Dentists: therapeutic orofacial use versus cosmetic use

Verdict: yes for therapeutic orofacial indications in most states; cosmetic use outside the orofacial region genuinely varies, and at least one large state expressly prohibits it.

Most state dental boards accept that Botox for therapeutic indications within the orofacial region — TMJ disorder, bruxism, masseter hypertrophy, gummy smile — falls within the scope of dentistry, on the reasoning that the orofacial musculature is part of the system dentists are licensed to evaluate and treat.

States that permit cosmetic use by dentists

Pennsylvania and New Jersey expressly allow dentists to administer Botox for both therapeutic and cosmetic purposes. Georgia permits dentists to perform injectable procedures following approved training. Mississippi's Board of Dental Examiners has determined that the application and use of injectable pharmacologics, whether intraorally or extraorally, falls within the scope of dentistry for all licensed Mississippi dentists — with the notable condition that administration occur within the dental office.

States that restrict dentists to therapeutic use

California is the clearest restriction among large states: provision of Botox solely for cosmetic purposes is outside the scope of dental practice, and California-licensed general dentists may not offer Botox and dermal filler injections for purely cosmetic indications. Dentists in restrictive states sometimes attempt to reframe cosmetic treatment as therapeutic; boards see through this, and the documentation is what gives it away.

Practical guidance for dentists

Do not rely on a "dental Botox" CME course to define legal scope — the course teaches technique, the board defines authority. Pull your state dental board's most recent scope-of-practice opinion, confirm whether the cosmetic and therapeutic distinction applies, and document the therapeutic indication contemporaneously rather than reconstructing it later. Dermal filler authority is more variable than neuromodulator authority in nearly every state and should be confirmed separately.

Estheticians, medical assistants, and unlicensed staff: the hard no

These three roles share an outcome but arrive at it differently, and each gets its own verdict because operators ask about them separately.

Estheticians and cosmetologists: the verdict

No, in every U.S. state, without exception. Estheticians, aestheticians, and cosmetologists are licensed under state cosmetology boards rather than medical or nursing boards. Their scope covers non-invasive surface skincare — facials, waxing, certain chemical peels, microdermabrasion, low-energy device treatments — and excludes any treatment that breaches the skin barrier with a prescription drug. Some states permit advanced services such as medium-depth peels or microneedling under a medical director's supervision. None of those expansions reach injection. An esthetician who injects is committing the unlicensed practice of medicine.

Medical assistants: the verdict

No, in every U.S. state, regardless of certification. Medical assistants are unlicensed personnel under every state's medical and nursing practice acts. No state board issues a medical assistant licence — "certified medical assistant" credentials come from private organisations and confer no clinical scope. An MA's permitted activity is whatever the supervising prescriber delegates within state limits, and every state excludes prescription drug injection from that set. MAs may room patients, take vitals, photograph for the record with consent, prepare the treatment area, sterilise instruments, and handle administrative work. They may not inject, may not consent the patient on the prescriber's behalf, and may not independently chart the clinical assessment.

Unlicensed staff and owners: the verdict

No, and this includes the owner. Non-clinical owners, receptionists, patient coordinators, and marketing staff hold no clinical scope whatsoever. A recurring enforcement pattern involves a non-clinical owner who has taken an injector course and treats when the clinical staff are busy. This is the highest-risk configuration in the sector: it is unlicensed practice of medicine by the owner, it voids the practice's malpractice coverage, and it exposes the medical director to discipline for failing to supervise. Ownership of the entity confers no authority to treat within it.

Supervision models: direct, indirect, and general

When a state says an injection must occur "under supervision," that word carries a defined meaning, and the three tiers impose very different operational burdens. Getting the tier wrong is one of the more common ways a technically-licensed practice still fails an audit.

Direct supervision

Requirement: the supervising provider is physically present on the premises and immediately available. Not reachable by phone, not in another building — on site. This is the tier North Carolina applies to LPNs performing cosmetic injections. Direct supervision does not usually require the supervisor to be in the treatment room or to watch the injection, but they must be able to intervene without delay. Practically, this means an LPN in North Carolina cannot inject on a day the qualifying provider is out.

Indirect supervision

Requirement: the provider is not on site but is readily reachable and has authorised the specific treatment in advance. This is the most common tier for RN injection in states that specify one. The authorisation must pre-date the treatment — a phone call after the fact does not convert an unauthorised injection into a supervised one. Document how the provider was reachable and the response-time expectation, because that is what a board asks for.

General supervision

Requirement: the provider has established written protocols and retains overall responsibility, without contemporaneous involvement in each treatment. This is the loosest tier and the one most often over-claimed. General supervision covers follow-up administration within an established treatment plan. It never covers the initial assessment of a new patient, and a practice that treats general supervision as blanket authority for anything its staff do is the standard fact pattern in "nominal medical director" enforcement.

Matching the tier to the role

Two rules keep practices out of trouble. First, the tier follows the least-privileged licence involved in the treatment — if an LPN injects in a state that permits it, the LPN's direct-supervision requirement governs even if an RN would have needed only indirect supervision. Second, the tier resets for each new patient: initial assessments require prescriber involvement regardless of what tier applies to follow-ups.

The good-faith examination and who may perform it

Every U.S. state requires a good-faith examination before a prescription cosmetic medication is administered, whatever the provider mix. It is the legal foundation of the provider-patient relationship — without it, no subsequent prescription, standing order, or nurse administration is valid. Boards treat its absence as a serious breach because it is the gateway through which most other scope violations enter.

Who may perform it

Only a prescriber: a physician, or an NP or PA to the extent the state's tier permits. In restricted NP states, the NP's ability to perform the exam depends on a current collaborative or protocol agreement being in force. An RN may never perform it. An LPN may never perform it — including in North Carolina, Kentucky, and Washington, where the permitted act is administration under someone else's order, not assessment. This is the single most important thing to understand about the three permissive LPN states: they expanded who may inject, not who may decide.

What it must contain

A documented evaluation by an authorised prescriber; the patient's relevant medical history; a focused physical examination appropriate to the proposed treatment; assessment of contraindications and risk factors; and a written treatment plan or standing order specific to that patient. Most states accept telehealth-based exams provided the prescriber is licensed in the patient's state and the encounter meets the same documentation standard as an in-person visit.

What it cannot be

Not an RN's intake interview. Not a checkbox form completed without a prescriber. Not a ninety-second video call with a prescriber who has no real intent to evaluate. Not a standing order applied to a patient who has never been seen. Several boards — notably the Florida Board of Medicine, the New York OPMC, and the Texas Medical Board — have published disciplinary actions specifically targeting "ghost" good-faith exams where prescriber involvement was nominal. The risk concentrates in telehealth operations working across state lines without per-state licensure.

Delegation documentation that proves compliance

Once a good-faith exam is on file, three documents appear in every compliant injectable practice. Operators use the terms interchangeably; they mean different things and authorise different conduct, and a board will ask for the right one.

The standing order

A pre-authorised treatment instruction signed by the prescriber that lets a properly licensed administrator perform a defined treatment for an established patient without contemporaneous re-evaluation. Appropriate for follow-up injections within an existing plan; never appropriate for new patients or treatments outside the documented plan. A standing order is a chart document, not a clinic policy — the patient must be identified or the treatment specifically indicated.

The written protocol

A clinic-level document defining the conditions under which delegated providers may treat under the prescriber's authority: patient selection criteria, treatment parameters, monitoring requirements, and adverse-event response. In Georgia (the APRN protocol agreement) and Texas (the physician delegation order), protocols are statutorily required and must contain specified elements. A protocol supplements a good-faith exam; it never substitutes for one.

The specific delegation order

An instruction for a single patient and a single treatment, signed by the prescriber after the good-faith exam. This is the strongest legal foundation for a delegated administration, and some states require it for first-time patients regardless of standing-order coverage.

The competency file

Often forgotten, and decisive in the permissive LPN states. North Carolina, Kentucky, and Washington all condition the authority on documented training and demonstrated competency in the specific technique. That means a file per injector containing the training record, an observed competency assessment signed by a qualified evaluator, and a re-assessment cadence. Without it, the board's conditional yes does not apply to your nurse — the authority is individual, not categorical.

Enforcement: what actually happens when someone injects out of scope

Three layers of consequence stack, and they land on different people. Understanding who bears which is what motivates owners to fix the problem before it is found.

Criminal exposure for the individual

Unlicensed practice of medicine is a misdemeanour or felony in most states. Several states have moved from civil cease-and-desist to criminal prosecution for unlicensed personnel performing injections, with charges frequently filed against the practice owner alongside the individual. For a licensed nurse acting outside scope the exposure is usually professional rather than criminal, but the licence consequence is severe and public.

Professional discipline for the supervisor

The supervising physician, NP, or PA who delegated improperly faces licence suspension, revocation, probation, or fines — and boards treat improper delegation as the supervisor's failure, not the subordinate's. Medical directors who were nominal in fact are prosecuted for exactly that nominality. Disciplinary actions are published, indexed, and permanently discoverable.

Civil liability and the insurance cliff

The layer that ends practices is insurance. Malpractice carriers typically void coverage for treatments performed outside scope, which means a vascular occlusion caused by an out-of-scope injector is uninsured. The practice absorbs the full cost of the claim plus defence. This is why the injector-roster audit is the highest-return compliance action available: it is free, takes an afternoon, and is the difference between a covered adverse event and an uncovered one.

How violations surface

Rarely through inspection. Overwhelmingly through patient complaints after an adverse outcome, competitor tips, disgruntled former staff, and the practice's own social media — boards do look at the Instagram post showing who is holding the syringe. For the broader failure landscape, see our most common med spa compliance violations reference.

Botox laws by state: how to read your own state's rules

Most people searching for "Botox laws by state" want a single chart. The reason no honest chart exists is that the answer is assembled from three or four separate legal instruments that live in different places and are updated on different schedules. Learning to assemble it yourself takes about an hour and is the difference between a defensible position and a guess.

The four documents that decide it

Start with the Medical Practice Act, which defines the practice of medicine and the physician's delegation authority. This tells you whether delegation is permitted at all and what conditions attach. Then read the Nurse Practice Act, which defines RN, LPN, and APRN scope. The practice act rarely names Botox — it describes categories of act, and cosmetic injection has to be reasoned into one. Third, and most useful, look for board position statements, advisory opinions, and declaratory statements. This is where boards say the quiet part out loud, and it is where every clear answer in this guide came from. Fourth, check facility and office-based-procedure rules, which in states like Florida and Texas impose obligations independent of who holds the syringe.

Where the answers actually hide

Board websites bury cosmetic guidance. The practice act itself will almost never mention neuromodulators. Search your board's site for the words "position statement," "advisory opinion," "declaratory statement," and "practice decision," each paired with "cosmetic," "aesthetic," and "dermatologic." Nevada calls its document a practice decision; North Carolina and Georgia call theirs position statements; Kentucky uses numbered advisory opinion statements; Washington uses advisory opinions; Louisiana and Florida use declaratory statements. Same substance, five different filing labels — which is precisely why aggregator charts miss them.

How to read a declaratory statement correctly

One trap deserves a warning. A declaratory statement resolves a question as applied to the petitioner's specific facts. It is persuasive evidence of how the board thinks, but it is not a rule of general application, and a practice whose facts differ materially cannot assume the same outcome. Florida's RN Botox statements are the standard example: they are frequently cited as though they granted blanket RN authority, when practitioners who have worked through them describe the resulting position as conditional. Read the facts the board was given, not just the conclusion.

Watch the effective dates

Scope guidance moves. Nevada's aesthetic practice decision was approved in January 2025; North Carolina's position statement and Georgia's were revised in 2024; Kentucky revised advisory opinions during 2025. A chart published in 2023 is describing a country that no longer exists in several states. Whatever source you rely on, confirm the date on the underlying board document rather than the date on the article summarising it, and re-check annually.

Hiring an injector: what to verify before the offer

The hiring decision is the single highest-leverage compliance action a med spa owner takes, because the injector you bring on defines the legal scope of the practice around them. Three checks, in order, before any offer letter goes out.

Verify the licence at the source

Pull the licence directly from the state board's public verification portal — never from a candidate's printed copy or a photograph. Confirm licence type, current status, absence of encumbrances or pending disciplinary action, expiration date, and disciplinary history. For NPs and PAs, verify prescriptive authority separately from the licence itself, because the two can diverge. Repeat this at every renewal cycle and keep the dated screenshot; "we checked at hire" is a weak answer three years later.

Match the licence to the state and the role

An NP licensed in Arizona cannot serve as your Florida injector without a Florida licence. An RN with a multistate compact licence covers compact states but needs single-state licensure elsewhere. A PA licensed in Texas must be re-papered for New York. And if you are considering an LPN for an injection role, this is where the analysis has to be explicit and written: confirm your state is one of the three that permit it, confirm you can actually staff the supervision tier it requires, and put the conclusion in the file. In North Carolina that means a qualifying provider physically on site whenever the LPN injects — a scheduling constraint, not just a paperwork one.

Confirm protocol fit before day one

The candidate must be able to operate inside the supervision structure you actually have. An independent-practice NP moving from Arizona to Florida needs to accept a written collaborative agreement, and that agreement should be drafted and ready to sign before their start date, not after. An RN arriving from a standing-order state into a delegation-order state needs the documentation set rebuilt first. Most onboarding scope failures trace to a candidate who started before these gaps were closed, then treated patients during the window while the paperwork caught up. Those treatments are the ones a board asks about.

By-state summary and where to go next

The table below summarises the headline rules across fifteen high-volume med spa states and links to our state guides. The LPN column carries over the verdicts from the table above. For the live, fully cited breakdown of all 51 jurisdictions, use our interactive who-can-inject tool, and start from the MedSpa Standards homepage if you are new here.

Several of these states have legislation pending in 2026 that may move them between tiers — most often expanding NP independence, occasionally tightening telehealth rules. Confirm before relying on any cell. For the full compliance picture beyond injection scope, see our flagship state-by-state reference, or browse the California, Florida, Texas, New York, Georgia, and Arizona state hubs.

Seven takeaways

1. Ask the role question before the state question. The licence determines the shape of the answer; the state determines the conditions attached to it.
2. Physicians and PAs are settled; NPs are the variable. Map your state to the AANP tier before hiring or delegating.
3. RNs may inject nearly everywhere but may never assess. The good-faith exam belongs to a prescriber in all fifty states.
4. The LPN answer is not uniform. North Carolina, Kentucky, and Washington permit it under conditions. Most states have not spoken, and silence means no.
5. Pharmacists cannot inject Botox as pharmacists anywhere. Vaccine and protocol authority does not extend to cosmetic neuromodulators.
6. Estheticians, MAs, unlicensed staff, and owners never inject. Certification is education, not authority.
7. Documentation is the whole defence. Good-faith exam, protocol, standing or delegation order, and a per-injector competency file — before the first injection, not after the complaint.

Frequently Asked Questions

Disclaimer: This article is general information for licensed med spa operators and is not legal or medical advice. Scope of practice rules vary by state and change frequently. Always verify current requirements with your state medical board, state board of nursing, and a licensed healthcare attorney before making compliance, hiring, or delegation decisions. The Corporate Practice of Medicine and ownership commentary touches on doctrines covered by the American Medical Association, but specific application requires state-specific counsel.